Rights and permissions
About this article
Cite this article
Destiny Pharma secures funding for anti-MRSA drugs. Pharmacoecon. Outcomes News 492, 14 (2005). https://doi.org/10.2165/00151234-200504920-00033
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504920-00033